HIV診断市場レポート：2030年までの動向、予測、競合分析

HIV診断の動向と予測

世界のHIV診断市場は、2024年から2030年までのCAGRが10.1％で、2030年までに推定76億米ドルに達すると予想されます。この市場の主な促進要因は、献血・輸血数の増加、ポイントオブケア機器・消耗品によるメリット、HIV関連の政府イニシアチブの増加です。世界のHIV診断市場の将来は、診断研究所や病院市場での機会により有望視されています。

HIV診断市場の洞察

Lucintelは、抗体検査が予測期間中に最も高い成長を遂げると予測しています。

北米は、医療インフラの成長とHIV感染率の高さにより、効率的な医療サービスの必要性が高まっているため、予測期間中も最大の地域であり続けると思われます。

よくある質問

Q1.市場規模は？

A1.世界のHIV診断市場は、2030年までに推定76億米ドルに達すると予想されています。

Q2.市場の成長予測は？

A2.世界のHIV診断市場は、2024年から2030年にかけてCAGR 10.1％で成長すると予測されます。

Q3.市場の成長に影響を与える主な促進要因は？

A3.この市場の主な促進要因は、献血・輸血数の増加、ポイントオブケア機器・消耗品によるメリット、HIV関連の政府イニシアチブの増加です。

Q4.市場の主要セグメントは？

A4.世界のHIV診断市場の将来は、診断研究所と病院市場における機会により有望です。

Q5.市場の主要企業は？

A5.HIV診断の主要企業は以下の通りです。

• Siemens Healthineers
• F. Hoffmann-La Roche
• Abbott Laboratories
• Danaher
• Thermo-Fisher Scientific

Q6.今後、最大となる市場セグメントは？

A6.Lucintelは、抗体検査が予測期間中に最も高い成長を遂げると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は？

A7.北米は、医療インフラの成長とHIV感染率の高さにより、効率的な医療サービスの必要性が高まっているため、予測期間中も最大の地域であり続ける。

Q8.レポートのカスタマイズは可能？

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界のHIV診断市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界のHIV診断市場動向（2018～2023年）と予測（2024～2030年）
• 製品別の世界のHIV診断市場
  • 消耗品
  • 機器
  • ソフトウェアとサービス
• 検査タイプ別の世界のHIV診断市場
  • 抗体検査
  • ウイルス量検査
  • CD4テスト
  • その他
• 最終用途別の世界のHIV診断市場
  • 診断研究所
  • 病院
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界のHIV診断市場
• 北米のHIV診断市場
• 欧州のHIV診断市場
• アジア太平洋のHIV診断市場
• その他地域のHIV診断市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 製品別の世界のHIV診断市場の成長機会
  • 検査タイプ別の世界のHIV診断市場の成長機会
  • 最終用途別の世界のHIV診断市場の成長機会
  • 地域別の世界のHIV診断市場の成長機会
• 世界のHIV診断市場における新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のHIV診断市場の能力拡大
  • 世界のHIV診断市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Siemens Healthineers
• F. Hoffmann-La Roche
• Abbott Laboratories
• Danaher
• Thermo-Fisher Scientific

HIV Diagnostic Trends and Forecast

The future of the global HIV diagnostic market looks promising with opportunities in the diagnostic laboratories and hospital markets. The global HIV diagnostic market is expected to reach an estimated $7.6 billion by 2030 with a CAGR of 10.1% from 2024 to 2030. The major drivers for this market are growing number of blood donations and transfusions, advantages provided by point-of-care equipment & supplies, and increasing HIV-related government initiatives.

A more than 150-page report is developed to help in your business decisions.

HIV Diagnostic by Segment

The study includes a forecast for the global HIV diagnostic by product, test type, end use, and region.

HIV Diagnostic Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Consumables
• Instruments
• Software & Services

HIV Diagnostic Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

• Antibody Tests
• Viral Load Tests
• CD4 Tests
• Others

HIV Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Diagnostic Laboratories
• Hospitals
• Others

HIV Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of HIV Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies HIV diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the HIV diagnostic companies profiled in this report include-

• Siemens Healthineers
• F. Hoffmann-La Roche
• Abbott Laboratories
• Danaher
• Thermo-Fisher Scientific

HIV Diagnostic Market Insights

Lucintel forecasts that antibody test is expected to witness the highest growth over the forecast period.

North America will remain the largest region over the forecast period due to growing healthcare infrastructure and the high prevalence of HIV infection that have resulted in a greater need for efficient healthcare services.

Features of the Global HIV Diagnostic Market

Market Size Estimates: HIV Diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: HIV Diagnostic market size by product, test type, end use, and region in terms of value ($B).

Regional Analysis: HIV Diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, test type, end use, and regions for the HIV diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the HIV diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the HIV diagnostic market size?

Answer: The global HIV diagnostic market is expected to reach an estimated $7.6 billion by 2030.

Q2. What is the growth forecast for HIV diagnostic market?

Answer: The global HIV diagnostic market is expected to grow with a CAGR of 10.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the HIV diagnostic market?

Answer: The major drivers for this market are growing number of blood donations and transfusions, advantages provided by point-of-care equipment & supplies, and increasing HIV-related government initiatives.

Q4. What are the major segments for HIV diagnostic market?

Answer: The future of the global HIV diagnostic market looks promising with opportunities in the diagnostic laboratories and hospital markets.

Q5. Who are the key HIV diagnostic market companies?

Answer: Some of the key HIV diagnostic companies are as follows.

• Siemens Healthineers
• F. Hoffmann-La Roche
• Abbott Laboratories
• Danaher
• Thermo-Fisher Scientific

Q6. Which HIV diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that antibody test is expected to witness the highest growth over the forecast period.

Q7. In HIV diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing healthcare infrastructure and the high prevalence of HIV infection that have resulted in a greater need for efficient healthcare services.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the HIV diagnostic market by product (consumables, instruments, and software & services), test type (antibody tests, viral load tests, CD4 tests, and others), end use (diagnostic laboratories, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global HIV Diagnostic Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global HIV Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global HIV Diagnostic Market by Product
  • 3.3.1: Consumables
  • 3.3.2: Instruments
  • 3.3.3: Software & Services
• 3.4: Global HIV Diagnostic Market by Test Type
  • 3.4.1: Antibody Tests
  • 3.4.2: Viral Load Tests
  • 3.4.3: CD4 Tests
  • 3.4.4: Others
• 3.5: Global HIV Diagnostic Market by End Use
  • 3.5.1: Diagnostic Laboratories
  • 3.5.2: Hospitals
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global HIV Diagnostic Market by Region
• 4.2: North American HIV Diagnostic Market
  • 4.2.1: North American HIV Diagnostics Market by Test Type: Antibody Tests, Viral Load Tests, CD4 Tests, and Others
  • 4.2.2: North American HIV Diagnostics Market by End Use: Diagnostic Laboratories, Hospitals, and Others
• 4.3: European HIV Diagnostic Market
  • 4.3.1: European HIV Diagnostics Market by Test Type: Antibody Tests, Viral Load Tests, CD4 Tests, and Others
  • 4.3.2: European HIV Diagnostics Market by End Use: Diagnostic Laboratories, Hospitals, and Others
• 4.4: APAC HIV Diagnostic Market
  • 4.4.1: APAC HIV Diagnostics Market by Test Type: Antibody Tests, Viral Load Tests, CD4 Tests, and Others
  • 4.4.2: APAC HIV Diagnostics Market by End Use: Diagnostic Laboratories, Hospitals, and Others
• 4.5: ROW HIV Diagnostic Market
  • 4.5.1: ROW HIV Diagnostics Market by Test Type: Antibody Tests, Viral Load Tests, CD4 Tests, and Others
  • 4.5.2: ROW HIV Diagnostics Market by End Use: Diagnostic Laboratories, Hospitals, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global HIV Diagnostic Market by Product
  • 6.1.2: Growth Opportunities for the Global HIV Diagnostic Market by Test Type
  • 6.1.3: Growth Opportunities for the Global HIV Diagnostic Market by End Use
  • 6.1.4: Growth Opportunities for the Global HIV Diagnostics Market by Region
• 6.2: Emerging Trends in the Global HIV Diagnostic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global HIV Diagnostic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global HIV Diagnostic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Siemens Healthineers
• 7.2: F. Hoffmann-La Roche
• 7.3: Abbott Laboratories
• 7.4: Danaher
• 7.5: Thermo-Fisher Scientific